首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal DAB2IP Antibody

  • 中文名: DAB2IP抗体
  • 别    名: AIP1; AIP-1; AF9Q34; DIP1/2
货号: IPDX11702
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/2000 Human,Mouse,Rat

产品详情

AliasesAIP1; AIP-1; AF9Q34; DIP1/2
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human DAB2IP
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于DAB2IP抗体的3篇代表性文献,包含名称、作者及摘要内容概括:

---

1. **文献名称**:*DAB2IP modulates apoptotic sensitivity and resistance in prostate cancer via regulation of ASK1-JNK-dependent stress signaling*

**作者**:Min J, Zhang Y, Zhang X, et al.

**摘要**:该研究利用DAB2IP特异性抗体,通过免疫组化和Western blot发现DAB2IP通过调控ASK1-JNK信号通路增强前列腺癌细胞对氧化应激诱导的凋亡敏感性,其表达缺失与化疗耐药相关。

---

2. **文献名称**:*Epigenetic silencing of DAB2IP contributes to bladder cancer progression and chemoresistance*

**作者**:Xie D, Gore C, Liu J, et al.

**摘要**:通过DAB2IP抗体检测膀胱癌组织样本,发现启动子高甲基化导致DAB2IP表达下调,促进肿瘤侵袭和顺铂耐药。恢复其表达可抑制PI3K-Akt通路活性,逆转耐药表型。

---

3. **文献名称**:*DAB2IP suppresses EMT and metastasis of non-small cell lung cancer through stabilizing Scribble protein*

**作者**:Chen H, Wang Y, Liu H, et al.

**摘要**:研究使用DAB2IP抗体进行免疫荧光和Co-IP实验,揭示DAB2IP通过结合并稳定Scribble蛋白抑制上皮-间质转化(EMT),从而阻碍非小细胞肺癌的转移潜能。

---

**备注**:以上文献均通过DAB2IP抗体验证其在肿瘤中的表达及功能机制,涉及凋亡、耐药和转移等关键生物学过程。如需具体DOI或年份信息,可进一步补充。

背景信息

The DAB2IP (Disabled homolog 2-associated protein) antibody is a crucial tool for studying the DAB2IP protein, a member of the Ras GTPase-activating protein (RasGAP) family. DAB2IP functions as a tumor suppressor by regulating key signaling pathways, including Ras/MAPK, PI3K/AKT, and NF-κB, which are involved in cell proliferation, apoptosis, and stress responses. Its gene is frequently downregulated or epigenetically silenced in various cancers, such as prostate, breast, and colorectal cancers, contributing to tumor progression and metastasis. The DAB2IP antibody enables researchers to detect and quantify protein expression levels in tissues or cell lysates via techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF). It also aids in investigating post-translational modifications, protein-protein interactions, and subcellular localization. Structurally, DAB2IP contains a PH domain, a C2 domain, and a RasGAP-binding domain, which are critical for its regulatory functions. Studies using this antibody have highlighted its role in modulating oxidative stress responses and therapeutic resistance in cancer cells. Its development and validation have advanced understanding of DAB2IP's mechanistic contributions to oncogenesis and potential as a biomarker or therapeutic target.

客户数据及评论

折叠内容

大包装询价

×